Expression profiling of MMA-1A and splice variant MMA-1B: New cancer/testis antigens identified in human melanoma

International Journal of Cancer

Volumn 98, Issue 4, 2002, Pages 547-553

  De Wit, Nicole J W ^a   Weidle, Ulrich H ^b   Ruiter, Dirk J ^a   Van Muijen, Goos N P ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Cancer testis antigen; Chromosome 21; Melanoma; Tumor progression

Indexed keywords

TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; BLADDER TUMOR; CHROMOSOME 21Q; HUMAN; HUMAN TISSUE; LUNG TUMOR; MELANOMA; METASTASIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOMA;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID;

EID: 0036533634     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10241     Document Type: Article

References (36)

1. The state-of-the-art in chemoprevention of skin cancer
2. Cutaneous melanoma
3. Differentially expressed genes in two human melanoma cell lines with different metastatic behaviour in nude mice using oligonucleotide arrays
4. Vascular density in melanoma xenografts correlates with vascular permeability factor expression but not with metastatic potential
5. Decreased expression of both the low-density lipoprotein receptor-related protein/&aagr; (2)-macroglobulin receptor and its receptor-associated protein in late stages of cutaneous melanocytic tumor progression
6. In vitro properties of human melanoma cells metastatic in nude mice
7. Differential expression and release of LFA-3 and ICAM-1 in human melanoma cell lines
8. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1 and tyrosinase in human melanoma cell lines and in human melanocytic lesions
9. Exceptional lethality for nude mice of cells derived from a primary human melanoma
10. Antiproliferative effects of intefferons against human bladder carcinoma cell lines in vitro
11. Normal FHIT transcripts in renal cell cancer- and lung cancer-derived cell lines, including a cell line with a homozygous deletion in the FRA3B region
12. The effects of gamma-interferon combined with 5-fluorouracil or 5-fluoro-2′-deoxyuridine on proliferation and antigen expression in a panel of human colorectal cancer cell lines
13. Structure, chromosomal localization and expression of 12 genes of the MAGE family
14. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
15. BAGE: A new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
16. XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma
17. Characterization of XAGE-1b, a short major transcript of cancer/testis-associated gene XAGE-1, induced in melanoma metastasis
18. Spermatid-specific expression of the novel X-linked gene product SPAN-X localized to the nucleus of human spermatozoa
19. CTp11, a novel member of the family of human cancer/testis antigens
20. SSX: A multigene family with several members transcribed in normal testis and human cancer
21. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
22. MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily
23. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen
24. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: A quality control study using real-time quantitative RT-PCR
25. Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: Basis for polyvalent CT vaccine strategies
26. Expression profile of genes coding for melanoma differentiation antigens and cancer/testis antigens in metastatic lesions of human cutaneous melanoma
27. Cancer-testis antigens: Targets for cancer immunotherapy
28. Introduction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells
29. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: Implications for tumour vaccines with melanoma-associated antigens
30. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
31. A phase I trial of an HLA-A1 restricted MAGE-3 epitope peptide with incomplete Freund's adjuvant in patients with resected high-risk melanoma
32. Recombination hot spots and human disease
33. A mutation (IVS8+0.6kbdelITC) creating a new donor splice site activates a cryptic exon in an Alu-element in intron 8 of the human β-glucuronidase gene
34. Inactivation of the p53 tumor suppressor gene via a novel Alu rearrangement
35. Genomic rearrangements of the APC tumor-suppressor gene in familial adenomatous polyposis
36. An Alu-mediated 7.1 kb deletion of BRCA1 exons 8 and 9 in breast and ovarian cancer families that results in alternative splicing of exon 10